CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Survival statistics for fallopian tube cancer
Survival statistics for fallopian tube cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for fallopian tube cancer and what they mean to you.
Survival by stage
Survival varies with each stage of fallopian tube cancer. Generally, the earlier fallopian tube cancer is diagnosed and treated, the better the outcome.
Survival by stage for fallopian cancer is reported as 5-year relative survival. Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer but who share similar characteristics (such as age and sex).
There are no specific Canadian statistics available for the different stages of fallopian tube cancer. The following information comes from a variety of sources. It may include statistics from other countries that are likely to have similar outcomes as in Canada.
|Stage||5-year relative survival|
Questions about survival
Talk to your doctor about your prognosis. A prognosis depends on many factors, including:
- your health history
- the type of cancer
- the stage
- certain characteristics of the cancer
- the treatments chosen
- how the cancer responds to treatment
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.
Taking action against all cancers
The latest Canadian Cancer Statistics report found that of all newly diagnosed cancers in 2017, half are expected to be lung, colorectal, breast and prostate cancers. Learn what you can do to reduce the burden of cancer.